AFWM
EW icon

Abich Financial Wealth Management’s Edwards Lifesciences EW Stock Holding History

Abich Financial Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$9.26K Buy
+119
New +$9.3K ﹤0.01% 469
2024
Q3 		– Sell
-142
Closed -$13.1K – 543
2024
Q2 		$13.1K Hold
142
– – 0.01% 254
2024
Q1 		$13.6K Buy
142
+23
+19% +$1.93K 0.01% 210
2023
Q4 		$9.07K Buy
+119
New +$8.28K 0.01% 214

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Abich Financial Wealth Management's EW Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Edwards Lifesciences (EW) in Q3 2025: 119 shares worth $9.26K. The stake represents ﹤0.01% of the portfolio and ranks #469 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in EW as recently as Q2 2024.

Abich Financial Wealth Management first reported a position in EW in Q4 2023 and has held it in 4 quarters since. The position peaked at $13.6K in Q1 2024. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Abich Financial Wealth Management held 119 shares of Edwards Lifesciences worth $9.26K as of Q3 2025.
  • Edwards Lifesciences was a new Abich Financial Wealth Management position in Q3 2025.
  • Edwards Lifesciences made up ﹤0.01% of Abich Financial Wealth Management's portfolio in Q3 2025, its #469 holding.
  • Abich Financial Wealth Management first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 4 quarters since.
  • Abich Financial Wealth Management's Edwards Lifesciences position peaked at $13.6K in Q1 2024.
  • 1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.